OBJECTIVE
To analyze the diagnostic capabilities of nucleic acid amplification (NAA) by real-time polymerase chain reaction (PCR) and microbiological examination of ejaculate sediment in determining the causes of male reproductive dysfunction.
MATERIAL AND METHODS
We examined 529 samples of ejaculate sediment from men aged 18—59 years with infertility and male accessory gland infection (Male Accessory Gland Infection/MAGI) between 2017 and 2021. Microorganisms for microbiological and molecular analysis were identified by matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry (MALDI-TOF MS) and real-time PCR (Androflor test, NAAT/PCR-RV/Androflor).
RESULTS
As a rule, significant bacteriospermia in ejaculate sediment was detected in Androflor molecular test compared to microbiological examination (402 (76%) and 237 (44.8%), respectively, p<0.01). Analysis of biotope by two methods indicates complete coincidence of microbial status only in 40 (7.6%) out of 529 cases. Otherwise, microbiological examination found no microbiota (83 (15.7%) sample) or spectrum of detected microorganisms differed. There were differences in the structure of isolated groups of microorganisms in cluster of predominant obligate anaerobic conditionally pathogenic microorganisms (p<0.01), gram-positive facultative anaerobic microorganisms Pseudomonas aeruginosa/Ralstonia spp./Burkholderia spp. (p<0.01), Haemophilus spp. (p<0.01) and monoculture Enterobacteriaceae spp./Enterococcus spp. (p<0.01). In the group with normal flora, NAA/RT-PCR/Androflor test revealed common associations of microorganisms (103 (81.1%)), microbiological examination revealed monoculture in most cases (216 (74%)) (p<0.01).
CONCLUSION
The Androflor molecular test is recommended for effective laboratory examination and timely treatment of men with reproductive dysfunction. Microbiological examination is also important since this method is valuable to analyze sensitivity of microorganisms to antibiotics and detect various enterobacteria requiring different therapeutic regimens.